Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rashmi K Benda

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer|February 26, 2004
Inflammatory breast carcinoma: outcomes with trimodality therapy for nonmetastatic diseaseStanley L Liauw, Rashmi K Benda, Christopher G Morris, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2003
Postmastectomy radiotherapy: patterns of recurrence and long-term disease control using electronsSteven J Feigenberg, Nancy Price Mendenhall, Rashmi K Benda, et al.
The Breast Journal|September 13, 2003
Metastatic lobular breast cancer presenting with malignant ascites: case report and review of literatureCassandra E Chow, Juan C Cendan, Glenn Herrmann, et al.
Cancer|February 6, 2003
Breast boost: are we missing the target?Rashmi K Benda, Gopika Yasuda, Anil Sethi, et al.
International Journal of Radiation Oncology, Biology, Physics|January 24, 2006
The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitisDaniel T Chang, Kenneth R Olivier, Christopher G Morris, et al.
Journal of Surgical Oncology|December 30, 2003
Breast-conserving therapy (BCT) for early-stage breast cancerRashmi K Benda, Nancy Price Mendenhall, D Scott Lind, et al.
Cancer|January 28, 2004
Should decisions on internal mammary lymph node irradiation be based on current lymphoscintigraphy techniques for sentinel lymph node identification?Rashmi K Benda, Juan C Cendan, Edward M Copeland, et al.
Clinical and Translational Radiation Oncology|September 12, 2022
Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trialJ Isabelle Choi, Kiran Prabhu, William F Hartsell, et al.
JCO Oncology Practice|March 3, 2026
Impact of a Precision Medicine Navigator on Genomic Test Utilization in Black Patients With Prostate CancerAlexander J Allen, Bansi Savla, Claudia Datnow-Martinez, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer|February 26, 2004
Inflammatory breast carcinoma: outcomes with trimodality therapy for nonmetastatic diseaseStanley L Liauw, Rashmi K Benda, Christopher G Morris, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2003
Postmastectomy radiotherapy: patterns of recurrence and long-term disease control using electronsSteven J Feigenberg, Nancy Price Mendenhall, Rashmi K Benda, et al.
The Breast Journal|September 13, 2003
Metastatic lobular breast cancer presenting with malignant ascites: case report and review of literatureCassandra E Chow, Juan C Cendan, Glenn Herrmann, et al.
Cancer|February 6, 2003
Breast boost: are we missing the target?Rashmi K Benda, Gopika Yasuda, Anil Sethi, et al.
International Journal of Radiation Oncology, Biology, Physics|January 24, 2006
The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitisDaniel T Chang, Kenneth R Olivier, Christopher G Morris, et al.
Journal of Surgical Oncology|December 30, 2003
Breast-conserving therapy (BCT) for early-stage breast cancerRashmi K Benda, Nancy Price Mendenhall, D Scott Lind, et al.
Cancer|January 28, 2004
Should decisions on internal mammary lymph node irradiation be based on current lymphoscintigraphy techniques for sentinel lymph node identification?Rashmi K Benda, Juan C Cendan, Edward M Copeland, et al.
Clinical and Translational Radiation Oncology|September 12, 2022
Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trialJ Isabelle Choi, Kiran Prabhu, William F Hartsell, et al.
JCO Oncology Practice|March 3, 2026
Impact of a Precision Medicine Navigator on Genomic Test Utilization in Black Patients With Prostate CancerAlexander J Allen, Bansi Savla, Claudia Datnow-Martinez, et al.
Pageof 1